ELDRUG S.A., located in Patras Science Park, is a spin off R&D Biotechnology Company established in January 2007 and based on research results and expertise obtained at the University of Patras under Professor Matsoukas and through his fruitful collaborations with University of Calgary, Canada and Victoria University, Australia. Laboratory Discoveries led to Novel Biochemical Methods, Medicinal Products and Potential Drugs, in the Treatment of Hypertension/Cardiovascular Diseases and Multiple Sclerosis.

Eldrug specializes in:

  • Synthesis of Bioactive Mimetic Molecules
  • Peptide Synthesis, Analysis, Identification, Development
  • Full Characterization, Purity Determination of Products, Development towards clinical investigation.
Company Details: 

Prof. John Matsoukas,

Patras Science Park
Patras, Rio
GR-265 04
T: (+30)2610 911.546,
E: eldrug@eldrug.gr, imats1953@gmail.com

Company File: